Last reviewed · How we verify

NCT04944667

Use of Virtual Reality for Procedural Planning of Transcatheter Aortic Valve Replacement

Completed NA Last updated 22 March 2022
What this trial tests

NA trial testing TAVR planning in Aortic Stenosis, Severe in 11 participants. Completed in 31 May 2021.

Timeline
1 May 2020
Primary endpoint
31 May 2021
31 May 2021

Quick facts

Lead sponsorCentro Medico Teknon
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment11
Start date1 May 2020
Primary completion31 May 2021
Estimated completion31 May 2021
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Centro Medico Teknon — full company profile →

Who can join

Eligibility, any sex, with Aortic Stenosis, Severe. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study sought to evaluate the impact of Virtual Reality (VR) tools in procedural planning of transcatheter aortic valve replacement (TAVR).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Use of virtual reality for procedural planning of transcatheter aortic valve replacement.
    Ruyra X, Permanyer E, Huguet M, Maldonado G. · · 2022 · cited 11× · PMID 36205608 · DOI 10.1093/icvts/ivac248

Verify or expand the search:

Other recruiting trials for Aortic Stenosis, Severe

Currently open trials in the same condition.

Other Centro Medico Teknon trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04944667.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing